Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Trinova Biochem is a private German life science company focused on distributing and supplying biomedical assays, reagents, culture media, and related laboratory products rather than developing a therapeutic drug pipeline. The company was founded in 1999 and is based in Gießen, Germany. Its portfolio spans genetic toxicology, microbiology, stem cell testing and toxicity, cell culture media, immunological products, and sepsis diagnostics, and it serves research and industrial customers across Europe. Trinova is the European distributor for MOLTOX genetic toxicology products, including Ames test systems used for mutagenicity testing under OECD 471 and related workflows. The company emphasizes stocked inventory, temperature-controlled logistics, and technical support, positioning it as a commercial supplier and channel partner in life sciences rather than a clinical-stage biotech developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Trinova Biochem.